Integrated Pharmacognostic and Computational Analysis of Hydrocotyle javanica Thunb. Phytochemicals as a Potential HER2 Tyrosine Kinase Inhibitor in Breast Cancer

Documenti analoghi

• Exploring the Pharmacodynamic and Molecular Interactions of Diosgenin as a Multitarget Therapeutic Agent in Breast and Ovarian Cancer Pathways
  di: Tanzim Nishad Ullah, et al.
  Pubblicazione: (2025)
• Computational Design of Pyrrolo[2,1‐f]triazine‐Based Dual Wild‐Type/Mutant EGFR Inhibitors: Pharmacophore Modelling, 3D ‐ QSAR , Quantum Chemistry, and Post‐ MD Studies for Breast Cancer Therapeutics
  di: Krishna Shevate, et al.
  Pubblicazione: (2025)
• Leveraging the Therapeutic Potential of Natural Peptide Panurgines: Hydrocarbon Stapling Strategy Enhances Their Efficacy Against Breast Cancer
  di: Zhongzhong Peng, et al.
  Pubblicazione: (2025)
• Comprehensive In Silico Analysis of Flavonoids in Breast Cancer Using Molecular Docking, ADME, and Molecular Dynamics Simulation Approach
  di: Gupta Dheeraj Rajesh, et al.
  Pubblicazione: (2025)
• Global Peptide Cancer Vaccine Market 2025 To 2034
  di: Sirsat, Nitin
  Pubblicazione: (2025)